Credit Suisse’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Credit Suisse’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-40,600	Closed	-$327K	–	4917
2014 Q1	$327K	Buy	+40,600	New	+$316K	﹤0.01%	4033
2013 Q3	–	Sell	-25,000	Closed	-$437K	–	4475
2013 Q2	$437K	Buy	+25,000	New	+$443K	﹤0.01%	3396

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Credit Suisse's ARIA Position: Q1 2017 in Review

Credit Suisse sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 216,373 shares — an estimated $2.69M sold.

Credit Suisse first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $9.58M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Credit Suisse reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Credit Suisse sold 216,373 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.69M.
Credit Suisse first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Credit Suisse's Ariad Pharmaceuticals Inc position peaked at $9.58M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.